merislon eisai tokyo japan 相關
廣告上個月有 超過 10 萬 名用戶曾瀏覽 hometogo.com
Book the Perfect Vacation Rental in Tokyo with up to 75% Discount! Best Tokyo Vacation Rentals from Your Favourite Sites. Find Your Dream Vacation Home Now!
- Offers under $199/Week
Find Great Rentals with the Best
Value for your Travel Money!
- Pet Friendly Rentals
Best Pet Friendly Rentals
Find Houses where Pets are Welcome!
- Vacation Home Rentals
Compare Millions of Rentals
and Book with Confidence!
- Last Minute Rentals
Find Instantly Bookable Rentals
And Start your Vacation Today!
- Search Vacation Rentals
Compare Million of Offers from
Numerous Trusted Partners
- No Hidden Costs
Up to 75% Discount
Book Now with no Extra Fees!
- Offers under $199/Week
上個月有 超過 100 萬 名用戶曾瀏覽 agoda.com
立即預訂可慳更多,Agoda®一直保證最低價! 我們全天候為你提供協助,出走都唔會注定一人!
搜尋結果
2024年3月30日 · Mar 30, 2024 | Business. Eisai Co., Ltd. announced today that it has entered into an agreement to divest its rights for vertigo and equilibrium disturbance treatment Merislon® (generic name: betahistine mesilate) and muscle relaxant Myonal® (generic name: eperisone hydrochloride) in Japan to Kaken Pharmaceutical Co., Ltd.
2024年4月1日 · On Apr 1, 2024. Eisai Co., Ltd. announced that it has entered into an agreement to divest its rights for vertigo and equilibrium disturbance treatment Merislon (generic name: betahistine mesilate) and muscle relaxant Myonal (generic name: eperisone hydrochloride) in Japan to Kaken Pharmaceutical Co., Ltd.
2024年4月18日 · TOKYO, Apr 18, 2024 - (JCN Newswire) - Eisai Co., Ltd. announced today that “The Research on Treatments for Alzheimer’s Disease Based on its Pathological Mechanisms” has received the Award for Science and Technology (Research Category) as a part of the FY2024 Commendation for Science and Technology by the Minister of Education, Culture, Sports, ...
2024年4月1日 · Eisai Co., Ltd. announced today that it has entered into an agreement to divest its rights for vertigo and equilibrium disturbance treatment Merislon (generic name: betahistine mesilate) and muscle relaxant Myonal (generic name: eperisone hydrochloride) in Japan
2024年4月12日 · MERISLON TAB 6MG Registration No.: HK-48603 Certificate Holder: EISAI (HONG KONG) CO LTD Certificate Holder Address: FLAT/RM D, 18/F, LEE & MAN 169 ELECTRIC ROAD, NORTH POINT, HONG KONG : Part 1 ...
2024年4月2日 · Eisai will continue to focus on creating and delivering products to target disease. Credit: mkfilm/Shutterstock.com. Eisai has signed an agreement for the divestiture of rights for Merislon and Myonal, two of its long-standing products in Japan, to Kaken Pharmaceutical. The transaction is valued at Y3.8bn ($25.10m).
2024年4月3日 · アジア地域における本剤の最初の承認. 東京, 2021年03月02日 - (JCN Newswire) - エーザイ株式会社(本社:東京都、代表執行役CEO:内藤晴夫)は、このたび、当社の香港の医薬品販売子会社であるEisai(Hong Kong)Co., Ltd.が、自社創製のオレキシン受容体拮抗薬「Dayvigo (R)」(一般名:レンボレキサント、日本製品名:「デエビゴ (R)」)について、「入眠困難、睡眠維持困難のいずれかまたはその両方を伴う成人の不眠症」の適応で新薬承認を取得しましたのでお知らせします。 本承認は、アジア地域(日本を除く)における本剤の最初の承認となります。